Harnessing AI agents and human expertise, researchers accelerate the design of innovative nanobodies to combat evolving SARS-CoV-2 variants. Study: The Virtual Lab: AI Agents Design New SARS-CoV-2 ...

During the COVID-19 pandemic, the team created nine nanobodies to fight COVID-19. Now, they've used this technology to develop two new nanobody inhibitors for Ebola: Nanosota-EB1 and Nanosota-EB2.

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

To overcome these problems, researchers have turned to single-domain antibodies, also known as nanobodies. These are derived from the variable domains of heavy-chain-only antibodies (VHHs ...

View Full Profile. Learn about our Editorial Policies. We primarily work with nanobodies, although we have shown that other proteins can be secreted too. Nanobodies are single domain antibodies ...

The team’s research has shown that nanobodies – a smaller, simple form of antibody generated by llamas and camels – can effectively target the SARS-CoV-2 virus that causes Covid-19. They found that ...